Difficulty: Medium
Average Score: 82%
Practice
A 54-year-old man with a history of recurrent pulmonary tuberculosis is placed on a multidrug regimen, including isoniazid. Despite long-term therapy with this agent, the treating physician has concerns about resistance. The most likely mechanism for this to occur is which of the following?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Mutation of Kat G. Isoniazid is a prodrug that requires activation by the enzyme KatG to become its active form. Resistance to isoniazid commonly arises due to mutations in the bacterial gene encoding KatG. These mutations lead to a decrease in the activation of isoniazid, rendering the drug less effective in treating tuberculosis.
Option A) Mutation of Acyl A is incorrect because Acyl A is not directly involved in the activation of isoniazid.
Option C) Prodrug deactivation is incorrect because the issue in resistance to isoniazid lies in the activation process, not deactivation.
Option D) Underexpression of InhA is incorrect as InhA is a target for another anti-tuberculosis drug, ethionamide, and not directly related to isoniazid resistance.
Educationally, understanding the mechanisms of drug resistance is crucial for healthcare providers to make informed decisions when treating patients with tuberculosis. Knowing how resistance occurs can help in selecting appropriate treatment regimens and preventing treatment failure. Understanding the specific mechanisms also aids in the development of new drugs and strategies to combat drug resistance in tuberculosis and other infectious diseases.
Option A) Mutation of Acyl A is incorrect because Acyl A is not directly involved in the activation of isoniazid.
Option C) Prodrug deactivation is incorrect because the issue in resistance to isoniazid lies in the activation process, not deactivation.
Option D) Underexpression of InhA is incorrect as InhA is a target for another anti-tuberculosis drug, ethionamide, and not directly related to isoniazid resistance.
Educationally, understanding the mechanisms of drug resistance is crucial for healthcare providers to make informed decisions when treating patients with tuberculosis. Knowing how resistance occurs can help in selecting appropriate treatment regimens and preventing treatment failure. Understanding the specific mechanisms also aids in the development of new drugs and strategies to combat drug resistance in tuberculosis and other infectious diseases.